Oregon wrestles with psychedelics as therapy

Psychedelic legalization in Oregon was widely promoted as a way to treat depression and trauma. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        'It's not medical': Oregon wrestles with how to offer psychedelics outside the health care system By Olivia Goldhill Rebecca Martinez of the Alma Institute stands in the treehouse where she had a transformational experience on psychedelic mushrooms. (AYŞE GÜRSÖZ FOR STAT) Psychedelic legalization in Oregon was widely promoted as a way to treat depression and trauma and, even among those figuring out regulations, there is confusion and debate around how medical Oregon’s psychedelics will be. Read More Sponsor content by ASGCT Over 30 scientific symposia and educational sessions cover the latest gene and cell therapy topics Session topics on the agenda for ASGCT’s 25th Annual Meeting, May 16-19, range from scientific and technological advances in gene and cell therapies to policy and regulatory issues impacting the field. Virtual or in-person attendance options offer different formats while providing the same high-quality research and comprehensive educational experience attendees expect. Both registration options include live-streaming and on-demand access. In-person attendees have opportunities to visit the poster hall, meet with exhibitors and enjoy networking receptions. Register today. More great reads from STAT this week Nurses, more powerful and visible after Covid, capitalize on new clout in Washington By Lev Facher With overdoses at record highs, a veterinary tranquilizer spreading through the U.S. drug supply poses new threats By Andrew Joseph Gilead’s Dan O’Day is pharma’s most charming executive — but with his deals falling apart, charm may not be enough By Matthew Herper ‘Why would I want that?’: My sister’s simple question reshaped my physician job search By Jennifer Adaeze Okwerekwu A glaring gap in Congress’ surprise billing law leaves patients on the hook for pricey, out-of-network lab tests By Bob Herman Opinion: Gaslighting of Black medical trainees makes residency something to ‘survive’ By Shenelle Wilson Prisons skimp on Covid treatments like Paxlovid, even as Biden plans to flood pharmacies with it By Nicholas Florko Researchers question whether Amazon’s partnership with Teladoc will really improve access to health care By Mohana Ravindranath Saturday, March 12, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser